Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CorMedix (CRMD) Other Non Operating Income (2016 - 2025)

CorMedix's Other Non Operating Income history spans 13 years, with the latest figure at $75195.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 863.3% year-over-year to $75195.0; the TTM value through Dec 2025 reached -$52000.0, down 67.74%, while the annual FY2025 figure was -$52000.0, 67.74% down from the prior year.
  • Other Non Operating Income for Q4 2025 was $75195.0 at CorMedix, up from -$72727.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $305048.0 in Q4 2022 and bottomed at -$72727.0 in Q3 2025.
  • The 5-year median for Other Non Operating Income is -$2875.5 (2021), against an average of $17138.3.
  • The largest annual shift saw Other Non Operating Income skyrocketed 2861.94% in 2022 before it crashed 1006.31% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$11595.0 in 2021, then skyrocketed by 2730.86% to $305048.0 in 2022, then tumbled by 109.57% to -$29199.0 in 2023, then skyrocketed by 126.73% to $7806.0 in 2024, then surged by 863.3% to $75195.0 in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Other Non Operating Income are $75195.0 (Q4 2025), -$72727.0 (Q3 2025), and -$16296.0 (Q2 2025).